A clinical trial testing an experimental vaccine for the Epstein-Barr virus (EBV) in people with MS is now recruiting ...

Epstein-Barr virus (EBV) causes infectious mononucleosis and is associated with several types of cancer and multiple sclerosis There are no current treatments or vaccines for EBV First participant ...

Undertaken in conjunction with Moderna, a fact sheet on the Eclipse Trial states, “If you or your child is eligible to participate and enroll in this clinical trial, you or your child will receive ...

November 7, 2011 — An Epstein-Barr virus (EBV) vaccine in the early phases of development may prove able to prevent infectious mononucleosis and EBV-associated cancers, without necessarily preventing ...

OPKO Health, Inc.’s OPK company, ModeX Therapeutics Inc., announced the dosing of the first participant in the Phase I study (NCT06655324) of an Epstein-Barr virus (EBV) vaccine candidate yesterday.

The UK is launching a groundbreaking Horizon trial to see if a vaccine can help people with multiple sclerosis by targeting the Epstein-Barr virus (EBV), a virus found in almost all MS patients. Led ...

Scientists have found the clearest evidence yet that Epstein-Barr virus (EBV) – which nearly all of us carry for life – is ...

A major scientific breakthrough has identified the Epstein-Barr virus (EBV) as the leading cause of multiple sclerosis (MS), a chronic inflammatory disease that affects nearly 3 million people ...

J. M. Grimm-Geris, S. K. Dunmire, L. M. Duval, E. A. Filtz, H. J. Leuschen, D. O. Schmeling, S. L. Kulasingam and H. H. Balfour Jr. Prophylactic vaccines against ...